Full Text

Turn on search term navigation

© 2019 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Correspondence to Yoo Jin Cho, Department of Health Promotion, Education, and Behavior, Arnold School of Public Health, University of South Carolina, Columbia, SC 29208, USA; [email protected] Heated tobacco products (HTPs), or ‘heat-not-burn tobacco products’, are battery-powered devices that deliver nicotine to the user by heating a tobacco stick, instead of combusting tobacco like conventional cigarettes or heating liquids like electronic cigarettes.1 2 Philip Morris International (PMI) launched its HTP, I Quit Ordinary Smoking (IQOS), in Japan in November 2014. Flavour capsules for conventional cigarettes work the same way and were first introduced in Japan in 2007, followed by their rapid introduction and growth in cigarette market share around the world.10 11 Capsule cigarette flavours originally included only menthol, but flavours have expanded to include fruits (eg, mango, cherry, grape, lemon, strawberry and orange) and drinks (mojito).12 13 Some capsule cigarettes even include two capsules with different flavours in the filter, and some brand varieties include multiple capsule flavours for different cigarette sticks inside a single pack.14 In Korea, there are at least 35 flavour capsule cigarette brand varieties available.13 Capsule heat-sticks are a key innovation for KT&G’s attempt to attain market share for its HTPs in Korea, where PMI successfully launched IQOS in June 2017.15 Indeed, while IQOS heat-sticks (HEETS) include a variety of flavours (tobacco, menthol, bubble gum and lime), no IQOS heat-sticks include capsules. Sales of HTPs increased in terms of both the volume and market share between May 2017 to March 2018, with approximately 163 million packs of heat-sticks sold, with each pack containing 20 heat-sticks.16 Government data suggest that heat-sticks accounted for an estimated 8.6% of the market share for all tobacco products in February 2018, which was almost triple their market share (3%) in July 2017.17 The market share for capsule heat-sticks is currently unknown, but the rapid introduction of the HTP innovation into the Korean market along with the high market share for capsule cigarettes suggests that they are likely to be successful. Capsule cigarettes were first introduced in Korea by BAT in 2010 (KENT Convertibles), and KT&G introduced the world’s first ultraslim capsule cigarette brand, Esse Change, in Korea in 2013.18 The market share of flavour capsule cigarette increased from 2.3% in 2012 to 15.0% in 2015 in Korea.19 Given that capsule cigarettes appeal to youth20 21 and are perceived as more stylish and less harmful than regular cigarettes,22 capsule heat-sticks may also appeal to youth.

Details

Title
Flavour capsule heat-sticks for heated tobacco products
Author
Yoo Jin Cho 1   VIAFID ORCID Logo  ; Thrasher, James F 1 

 Department of Health Promotion, Education, and Behavior, Arnold School of Public Health, University of South Carolina, Columbia, South Carolina, USA 
Pages
e158-e159
Section
Industry watch
Publication year
2019
Publication date
Dec 2019
Publisher
BMJ Publishing Group LTD
ISSN
09644563
e-ISSN
14683318
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2348235066
Copyright
© 2019 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.